How does hepatitis B virus infection react to hepatocellular carcinoma treatment?
Open Access
- 21 December 2011
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 27 (1) , 1-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinomaAlimentary Pharmacology & Therapeutics, 2011
- Immunosuppression following surgical and traumatic injurySurgery Today, 2010
- A Comparative Study of Antiviral Therapy After Resection of Hepatocellular Carcinoma in the Immune-Active Phase of Hepatitis B Virus InfectionAnnals of Surgical Oncology, 2009
- The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinomaJournal of Gastroenterology, 2009
- Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus‐related hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2007
- Safety and efficacy of lamivudine after radiofrequency ablation in patients with hepatitis B virus-related hepatocellular carcinomaHepatology International, 2007
- Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virusHepatology Research, 2007
- Hepatocellular Carcinoma and Hepatitis B VirusSeminars in Liver Disease, 2006
- Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinomaJournal of Hepatology, 2004
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003